Clinical Trials Directory

Trials / Completed

CompletedNCT06740500

Effect of Bifidobacterium Animalis Subsp. Lactis Bi66 Supplementation on Gut Function in Healthy Adults

Effect of Bifidobacterium Animalis Subsp. Lactis Bi66 Supplementation on Gut Function in Healthy Adults: a Double-blind Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
117 (actual)
Sponsor
Huazhong University of Science and Technology · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to learn the effect of Bifidobacterium animalis subsp. lactis Bi66 supplementation on gut function in healthy adults. The main questions it aims to answer are: 1. Does Bi66 affect the gut function(bowel movement frequency and stool form)? 2. Does Bi66 affect the gut microbiota and short-chain fatty acids ? Researchers will compare probiotic Bi66 to a placebo (a look-alike substance that contains no Bi66) to see if Bi66 works to affect gut function. Participants will 1. Take Bi66 or a placebo every day for 8 months 2. Return the used sachets and stool diaries every 7 days and record bowel movement frequency per week and Bristol Stool Scale 3. Have checkups, including questionnaire survey, physical measurement, dietary survey, collection and detection of biological samples at baseline, week 4, week 8

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbioticprobiotic sachet mainly contains Bifidobacterium animalis subsp. lactis Bi66 and maltodextrin.
DIETARY_SUPPLEMENTPlaceboMaltodextrin

Timeline

Start date
2025-10-17
Primary completion
2025-12-30
Completion
2026-01-15
First posted
2024-12-18
Last updated
2026-03-30

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06740500. Inclusion in this directory is not an endorsement.